An observational study in Sepsis and Septic Shock, sponsored by Charite University, Berlin, Germany. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-01.
Sponsored by Charite University, Berlin, Germany · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 56 studies in Shock, Septic with a site in Germany — 7 open to participants now, 7 under way, none of them phase 3. Shock, Septic · Germany.
Among the 56 studies in Shock, Septic with a site in Germany, this one has the largest planned enrollment of the 26 observational ones that give a count, is one of 5 that started in 2022, is one of 27 observational ones, and was the 51st registered.
1,084 studies on the registry are indexed under Shock, Septic; 236 are open to participants now.
Browse Shock, Septic studies →7 of the 56 studies in Shock, Septic with a site in Germany are open now. Recruiting first, the newest first:
Artcline GmbH · Sites in Germany
Ages 18+
Hannover Medical School · Sites in Germany, Austria, Switzerland
Ages 18–80
CytoSorbents, Inc · Sites in Germany, Austria, Italy and 3 more countries
Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Seps · Sites in Germany
Ages 18–99
RWTH Aachen University · Sites in Germany, Austria
Ages 18+
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 137 Shock, Septic studies recruiting now, 103 (75%) set no upper age limit and 18 (13%) stop at 75 or younger; 11 take children under 18; 14 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
56 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 6 · Phase 3 8
First in 2002; this study’s year is marked. 5 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 10,000 is above the median of 108 across 408 observational studies indexed under Shock, Septic.
Median enrollment 277 across the 29 interventional studies, 275 across the 26 observational. Of the 33 that completed or were terminated, 4 (12%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 56 have an industry lead sponsor. The 10 most frequent:
Charite University, Berlin, Germany is the lead sponsor of 857 studies on the registry; 128 are open to participants now.
Charite University, Berlin, Germany has 3 studies filed under Shock, Septic — fewer than ten, so there is no comparison to draw.
4 of the studies in Shock, Septic with a site in Germany that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05688774Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe SepsStudy of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases and Immunosuppression | 2027-02-28 |
| NCT07388628Artcline GmbHARTICE® Real Data Collection & Observational Trial, Phase 4 Study | 2027-09 |
| NCT03334006RWTH Aachen UniversityProspective, Randomized Trial of Personalized Medicine With Pentaglobin® After Surgical Infectious Source Control in Patients With Peritonitis | 2027-09 |
| NCT07817043University Medicine GreifswaldMicrobiology Operations & Time Optimization in Sepsis | 2027-10-01 |
Add all 4 to your calendar (.ics) → With an account.
Among the 56 studies in Shock, Septic with a site in Germany, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Retrospective observational study to develop a Machine Learning Algorithm to evaluate parameters collected from routine data for the diagnosis of sepsis and septic shock and their influence on time to diagnosis and patient outcome.
Retrospective routine data from the medical records of the department of anesthesiology and operative intensive care from 01. 01. 2007 to 31. 12. 2021 are analyzed in digital form.
The first step is the development of a machine learning algorithm (MLA). This MLA will be validated and analyzed for his predictive value with regard to early diagnosis of sepsis/septic shock depending on the conceptual value of detection variables (Sepsis-3 vs. SIRS). Further analysis will focus on improvement of accuracy for the MLA and the effect of these detection variables on quality of treatment processes and also on economic consequences like cost and revenue.
Timeline:
1,084 studies on the registry are indexed under Shock, Septic; 236 are open to participants now.
This study's planned enrollment of 10,000 is above the median of 108 across 408 observational studies indexed under Shock, Septic.
Browse Shock, Septic studies →Charite University, Berlin, Germany is the lead sponsor of 857 studies on the registry; 128 are open to participants now.
Compared within Shock, Septic, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Sepsis. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Intensive care unit patients (female, male, miscellaneous) from the age of 18 years with an intensive care stay of > 24 hours in an intensive care unit since 01. 01. 2007 from the Department of Anesthesiology and Operative Intensive Care Medicine (CCM/CVK)
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Sepsis/septic shock
Development of a machine learning algorithm (MLA) for the prediction of sepsis/septic shock from hospital routine data.
Time frame: 01.01.2007 -31.12.2021
Predictive accuracy
Evaluation of the predictive accuracy (= predictive value) of the respective sepsis diagnostic algorithm (i.e. comparison of the concepts SIRS and Sepsis-3)
Time frame: 01.01.2007 -31.12.2021
Diagnostic accuracy
Identification of additional variables for diagnostic accuracy (laboratory values, clinical parameters and vital-sign monitor parameters and other relevant health data
Time frame: 01.01.2007 -31.12.2021
Performance indicators
Evaluation of performance indicators of clinical routine processes (Intensive care quality indicators)
Time frame: 01.01.2007 -31.12.2021
Case costs
Case costs related to hospitalization
Time frame: 01.01.2007 -31.12.2021
Revenues
Revenues related to hospitalization
Time frame: 01.01.2007 -31.12.2021
Plan to share: No
No publications or documents are linked to this record.
Started Jul 2022 (actual). Primary completion is estimated for Sep 2026, 50 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Charite University, Berlin, Germany →